NEW YORK (Reuters Health) – In patients with active psoriatic arthritis, daily oral upadacitinib produces significantly more improvement than placebo,
Upadacitinib Shows Benefit in Psoriatic Arthritis, Higher Dose Bests Adalimumab

besthealthtale.com
Home ยป
NEW YORK (Reuters Health) – In patients with active psoriatic arthritis, daily oral upadacitinib produces significantly more improvement than placebo,